Our mission is to take a direct and clinical approach to the prevention, early diagnosis and education of patients with prostate cancer. Genetic Testing Prostate cancer is genetically inherited and it is one of the main contributing factors in developing the disease.

Our goal is to promote clinical and basic science research in genetic testing for the patients; their relatives and their descendants.

The aim is to help the scientific world find the genetic signatures that predispose to the development of prostate cancer and use this to clinically impact those afflicted with and those predisposed based upon genetic heritage. Education for Patients and Physicians: The global impact of lack of education about prostate cancer is staggering. In the United States, most men diagnosed early with prostate cancer have a greater than 90% chance of cure.

The majority of this is based upon early diagnosis from screening.

This survival rate is not reflected worldwide. Educating patients on the virtues of regular prostate cancer screening along with their treatment options is one of our key missions. In addition, we support the education of physicians on the optimal treatment modalities. Global Screening Promoting the global screening for prostate cancer is a monumental task for any foundation. One of our key missions is to work with governments, organizations and programs worldwide and support their efforts in screening and education in their local environment.